SCHEMBL12427075

SCHEMBL12427075

COCc1ccc(-c2ccccc2)nc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.59
RAB9A P51151 5/20 0.59
NPC1 O15118 3/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
KDM4E B2RXH2 8/20 0.49
ALDH1A1 P00352 8/20 0.49
HSD17B10 Q99714 8/20 0.49
MAPT P10636 7/20 0.49
TSHR P16473 3/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 1/20 0.49
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
SQOR Q9Y6N5 2/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12427065 0.83 HPGD (0.49) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL12427062 0.83 SQOR (0.53) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL17450996 0.82 RAB9A (0.48) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL14943936 0.78 HPGD (0.43) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL2300943 0.77 ALDH1A1 (0.50) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL3208786 0.76 L3MBTL1 (0.43) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL14931843 0.76 HPGD (0.41) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL25047250 0.75 SQOR (0.59) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL27518492 0.74 SQOR (0.53) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL13831044 0.74 MEN1 (0.54) HPGDRAB9ANPC1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195993-A1 PPAR AGONIST COMPOUNDS, PREPARATION AND USES GENFIT (FR) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195993-A1 PPAR AGONIST COMPOUNDS, PREPARATION AND USES PPARD, PPARA, PPARG HPGD 1128/4885RAB9A 2825/4885NPC1 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.